Relapse rates after detox and rehabilitation remain a significant challenge in the treatment of substance use disorder (SUD). Studies show that between 40% and...
In a surprising and strategic move, FOXO Technologies (NYSE American: FOXO), a biotech company known for its advancements in epigenetics and AI-driven health solutions,...
A bipartisan group of five U.S. senators recently announced a significant legislative effort aimed at improving addiction treatment in prisons. The bill, called the...
As the United States adjusts to the post-pandemic landscape, addiction treatment providers are navigating a fast-evolving field shaped by new patient demands, persistent policy...
Traditional addiction treatment models often require individuals to leave their homes, jobs, and families to receive care in a facility-based setting. While this approach...